Hyperpituitarism is a condition in which the pituitary gland produces too much of one or more of its hormones. The pituitary, a pea-sized gland at the base of the brain, controls growth, metabolism, reproduction, and stress response. When it overproduces, the excess hormones create a cascade of problems throughout the body. The cause is almost always a noncancerous tumor called a pituitary adenoma, and the specific symptoms depend entirely on which hormone is being overproduced.
How the Pituitary Gland Works
The front portion of the pituitary gland produces six key hormones: growth hormone, prolactin, the hormone that triggers cortisol production (ACTH), the hormone that stimulates the thyroid (TSH), and two hormones that regulate the reproductive system (LH and FSH). Each of these hormones acts as a chemical signal to other glands and organs. When a tumor develops on the pituitary, it can churn out excessive amounts of one or more of these hormones, throwing the downstream systems out of balance.
Pituitary adenomas are far more common than most people realize. A large meta-analysis of autopsy and imaging studies estimated that roughly 16.7% of people have a pituitary adenoma, with most never causing symptoms. Tumors smaller than 10 millimeters are called microadenomas, while those 10 millimeters or larger are macroadenomas. Even macroadenomas often go undetected, occurring in about 1 in 600 people.
Types of Hyperpituitarism
The condition takes different forms depending on which hormone-producing cells form the tumor. Each type has a distinct set of effects on the body.
Prolactin Excess (Prolactinoma)
Prolactinomas are the most common type, accounting for at least 40% of all pituitary tumors. They occur three times more often in women than in men. Excess prolactin disrupts the reproductive system. In women, this typically means irregular or absent periods, milky breast discharge unrelated to pregnancy, vaginal dryness, and sometimes excess facial or body hair. In men, it can cause erectile dysfunction, reduced body hair, and smaller muscles.
Because prolactin-producing cells share a developmental lineage with growth hormone and thyroid-stimulating cells, prolactinomas sometimes secrete those hormones too, creating overlapping symptoms.
Growth Hormone Excess
Too much growth hormone leads to either gigantism or acromegaly, depending on when it starts. In children and adolescents whose growth plates haven’t yet fused, excess growth hormone drives extreme linear growth, resulting in gigantism. In adults, the same hormone excess can’t increase height because the growth plates are closed. Instead, it causes acromegaly: gradual enlargement of the hands, feet, and facial features, along with joint pain, thickened skin, and organ enlargement. Most people with gigantism also develop acromegalic features, and many adults with acromegaly are taller than average. The two conditions exist on a continuum.
ACTH Excess (Cushing’s Disease)
When a pituitary tumor overproduces ACTH, it forces the adrenal glands to make too much cortisol, the body’s primary stress hormone. This specific scenario is called Cushing’s disease and is the most common cause of chronically elevated cortisol. The effects are widespread and often dramatic: weight gain concentrated in the face, upper back, and midsection while the arms and legs stay thin; wide purple stretch marks on the abdomen, breasts, and hips; easy bruising; muscle weakness; and slow wound healing. Women may develop excess facial hair and irregular periods. Men may experience reduced sex drive and erectile dysfunction. Children with Cushing’s disease typically gain weight while growing more slowly than their peers.
Untreated Cushing’s disease is particularly dangerous. Patients face two to nearly seven times the normal risk of heart attack, stroke, and heart failure. Cardiovascular events, blood clots, and severe infections are the leading causes of death when the condition goes unmanaged.
TSH-Secreting Tumors
Tumors that overproduce thyroid-stimulating hormone are rare, representing less than 1% of functioning pituitary tumors, with only about 0.15 cases per million people each year. They cause the thyroid to become overactive, leading to symptoms of hyperthyroidism: weight loss, rapid heartbeat, anxiety, heat intolerance, and tremors.
Gonadotropin-Secreting Tumors
Tumors producing excess reproductive hormones (LH or FSH) are also uncommon. Most gonadotropin-producing adenomas are actually “silent,” discovered incidentally during surgery. When they do cause symptoms, premenopausal women may notice menstrual irregularities, men may develop signs of low testosterone, and children may enter puberty abnormally early.
How Hyperpituitarism Is Diagnosed
Diagnosis starts with blood tests measuring hormone levels. If initial results are abnormal, more targeted testing follows. For suspected growth hormone excess, the gold standard is an oral glucose tolerance test: you drink a sugary solution containing 75 grams of glucose, and your blood is tested afterward. Normally, the sugar load suppresses growth hormone. In acromegaly, growth hormone stays elevated, failing to drop below the diagnostic cutoff. A blood marker called IGF-1, which reflects overall growth hormone activity, is also measured.
For suspected Cushing’s disease, a low-dose dexamethasone suppression test is used first. You take a small dose of a synthetic steroid, and your cortisol is measured the next morning. Healthy cortisol production will drop in response; in Cushing’s, it won’t. A follow-up test combining dexamethasone with a brain hormone called CRH helps distinguish true Cushing’s disease from “pseudo-Cushing’s,” a pattern of elevated cortisol sometimes seen in people with depression, heavy alcohol use, poorly controlled diabetes, or obesity.
Once blood work confirms hormone overproduction, MRI of the pituitary is the next step. Dynamic contrast-enhanced MRI is the gold standard for locating the tumor. This technique involves injecting a contrast dye and taking rapid images at multiple time points. Adenomas show up as areas that absorb the dye more slowly than surrounding tissue. This approach detects about 89% of microadenomas, compared to only 56% with standard imaging. Some tumors smaller than 7 millimeters are visible only on dynamic imaging.
Treatment Options
Treatment depends on which hormone is overproduced, the size of the tumor, and how aggressively it’s growing.
Medication
Prolactinomas are unique among pituitary tumors because medication is usually the first-line treatment rather than surgery. Drugs that mimic the brain chemical dopamine shrink the tumor and reduce prolactin levels. These medications are typically taken once or twice a week and are effective for most patients, though higher doses are sometimes needed for larger tumors. One consideration with long-term, high-dose use is the potential for heart valve problems, so periodic monitoring is standard.
For acromegaly, medications work differently. Drugs that mimic the hormone somatostatin reduce growth hormone secretion and can slow tumor growth. They’re given as injections, usually monthly. Another option blocks growth hormone from attaching to its receptors throughout the body, effectively neutralizing its effects even though the pituitary keeps producing it. The dose is adjusted based on blood markers until hormone levels normalize.
Surgery
When medication isn’t sufficient or isn’t appropriate, surgery through the nasal passage (transsphenoidal surgery) is the standard approach. The surgeon reaches the pituitary through the nose and sinuses, avoiding the need to open the skull. Success rates vary by tumor type. TSH-secreting tumors respond best, with about 88% achieving remission after surgery. Cushing’s disease tumors have a success rate around 72%, and growth hormone tumors around 59%. Prolactinomas have the lowest surgical success rate at roughly 42%, which is one reason medication is preferred for them.
The most common complication after surgery is new hormone deficiencies, occurring in about 15% of cases. This happens when normal pituitary tissue is damaged during tumor removal, and it requires lifelong hormone replacement. Persistent problems with water balance regulation occur in about 5% of patients, and spinal fluid leaks happen in about 3%.
Radiation
When surgery doesn’t fully resolve the problem or when a tumor returns, radiation therapy targeting the pituitary is sometimes used. It works more slowly than surgery, often taking months or years to bring hormone levels down, and carries its own risk of damaging healthy pituitary tissue over time.
What Happens Without Treatment
The long-term consequences of untreated hyperpituitarism are serious and depend on the specific hormone involved. Uncontrolled cortisol excess carries the highest cardiovascular risk, with dramatically increased rates of heart attack, stroke, and blood clots. Uncontrolled growth hormone excess leads to progressive changes in appearance, joint deterioration, and increased risk of heart disease and diabetes. Untreated prolactin excess causes ongoing reproductive problems and bone thinning from prolonged hormone disruption. Large tumors of any type can grow to compress the optic nerve, with loss of peripheral vision often being the first warning sign, potentially progressing to more significant vision loss if the pressure continues.